| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9941021 | American Journal of Hypertension | 2005 | 5 Pages |
Abstract
Measurement of systolic BP alone does not reliably indicate the degree of vasoconstriction or vasodilation that exists in patients with CHF. Measurement of SVRI by ICG may help guide determination of need and tolerance for vasodilating medications in CHF.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Charles W. Parrott, Cheryl Quale, Deborah L. Lewis, Sara Ferguson, Rhonda Brunt, Susan Glass,